{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:58:35Z","timestamp":1772801915214,"version":"3.50.1"},"reference-count":0,"publisher":"Portico","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2013.49.2.1930525","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T10:18:51Z","timestamp":1429179531000},"page":"105","source":"Crossref","is-referenced-by-count":27,"title":["The development of regorafenib and its current and potential future\nrole in cancer therapy"],"prefix":"10.3730","volume":"49","author":[{"family":"Davis, S.L.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Eckhardt, S.G.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Messersmith, W.A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jimeno, A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2013]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:36:42Z","timestamp":1685453802000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddq57c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2013.49.2.1930525","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}